պ

Daniel Weiss, M.D., Ph.D.

Professor of Medicine, Pulmonary Medicine, Larner College of Medicine

Dr. Daniel Weiss M.D. Ph.D.
Alma mater(s)
  • M.D. Mount Sinai School of Medicine, New York, NY 1981-1988
  • Ph.D. Pharmacology/Biomedical Sciences, Mount Sinai School of Medicine of the City University of New York, NY 1981-1987
  • B.A. Cum Laude, Anatomy and Physiology/Biology Cornell University, Ithaca, NY 1977-1981
Affiliated Department(s)

Department of Medicine, Larner College of Medicine

BIO

Dr. Daniel Weiss M.D. Ph.D. began his education at Cornell University studying Anatomy and Physiology/ Biology where he graduated Cum Laude with his bachelor's degree in 1981. He then began pursuing his PhD and MD at the Mount Sinai School of Medicine of the City University of New York where he graduated in 1988 and received a doctoral dissertation award for “Thesis of Unusual Distinction”. His work brought him from New York to Seattle, Washington where he worked in pulmonary and critical care medicine at the University of Washington. He later moved to պ to work as an assistant and associate professor in cell and molecular biology up until he became a professor in the department of medicine in 2011.

Dr. Weiss currently works as a pulmonary and critical care specialist and splits his time between leading his research team in several projects in the Weiss Laboratory and working at the hospital doing clinical work. Through his time working in research and academia, he has been able to obtain many research grants to continue his work on improving the lung health of patients. One of his more notable grants was recently awarded to focus on lung damage caused by COVID-19 which is a vital area of study now and looking forward to the future. Many of his works have been published and most significantly, was his work on stem cells and cell therapies in lung biology and lung diseases. Weiss’s passion for improving the health of patients afflicted with lung diseases has pushed him to bring together the great minds of a team of engineers, scientists, and laboratory specialists to better understand the physiology of these diseases and to create advanced therapies to help treat and prevent them.

Publications

Awards and Achievements

  • New York State Regent’s Scholarship 1977-1981
  • Cum laude, Cornell University, Ithaca, NY. 1981
  • Full Scholarship: Medical Scientist Training Program -Mt. Sinai School of Medicine 1981-1988
  • Doctoral Dissertation Award "Thesis of Unusual Distinction" City University of New York 1987

Area(s) of expertise

Pulmonary and critical care specialist

Bio

Dr. Daniel Weiss M.D. Ph.D. began his education at Cornell University studying Anatomy and Physiology/ Biology where he graduated Cum Laude with his bachelor's degree in 1981. He then began pursuing his PhD and MD at the Mount Sinai School of Medicine of the City University of New York where he graduated in 1988 and received a doctoral dissertation award for “Thesis of Unusual Distinction”. His work brought him from New York to Seattle, Washington where he worked in pulmonary and critical care medicine at the University of Washington. He later moved to պ to work as an assistant and associate professor in cell and molecular biology up until he became a professor in the department of medicine in 2011.

Dr. Weiss currently works as a pulmonary and critical care specialist and splits his time between leading his research team in several projects in the Weiss Laboratory and working at the hospital doing clinical work. Through his time working in research and academia, he has been able to obtain many research grants to continue his work on improving the lung health of patients. One of his more notable grants was recently awarded to focus on lung damage caused by COVID-19 which is a vital area of study now and looking forward to the future. Many of his works have been published and most significantly, was his work on stem cells and cell therapies in lung biology and lung diseases. Weiss’s passion for improving the health of patients afflicted with lung diseases has pushed him to bring together the great minds of a team of engineers, scientists, and laboratory specialists to better understand the physiology of these diseases and to create advanced therapies to help treat and prevent them.

Publications

Awards and Achievements

  • New York State Regent’s Scholarship 1977-1981
  • Cum laude, Cornell University, Ithaca, NY. 1981
  • Full Scholarship: Medical Scientist Training Program -Mt. Sinai School of Medicine 1981-1988
  • Doctoral Dissertation Award "Thesis of Unusual Distinction" City University of New York 1987

Areas of Expertise

Pulmonary and critical care specialist

Academic Appointments

  • Professor, Department of Medicine, Fletcher Allen Health Care, University of Vermont, Burlington VT 2011-present

  • Associate Professor, Department of Medicine, Fletcher Allen Health Care, University of Vermont Burlington, Vermont 2006-2011

  • Associate Professor Cell and Molecular Biology, University of Vermont, Burlington 2006-present

  • Assistant Professor Cell and Molecular Biology, University of Vermont, Burlington 2001-2006

  • Assistant Professor, Department of MedicineFletcher Allen Health Care, University of VermontBurlington, Vermont 2001-2006

  • Clinical Assistant Professor, Pulmonary and Critical Care Medicine University of Washington, Seattle, Washington 2001

  • Clinical Instructor, Pulmonary and Critical Care Medicine University of Washington, Seattle, Washington 1997-2001

  • Acting Instructor, Pulmonary and Critical Care Medicine University of Washington, Seattle, Washington 1995-1997

  • Acting Instructor, Department of Emergency Services University of Washington, Seattle, Washington 1993-1996

 

Research Grants

  • Individual National Research Service Award, NIH-NHLBI HL09134, $104,400 “Feedback Regulation of Collagen Synthesis in Lung Injury” 1994-1997

  • American Lung Association Research Grant, $80,000 “Regulation of Collagen Synthesis in Acute Lung Injury” 1997-1999

  • National Cystic Fibrosis Foundation Pilot and Feasibility Grant, $80,000 “Perfluorocarbon-Enhancement of Airway Gene Delivery” 1998-2000

  • Core Center for Cystic Fibrosis and Gene Therapy Research University of Washington Medical Center/Children’s Hospital Pilot and Feasibility Project Accepted as New Project in Core Grant Renewal, NHLBI, February 1998 “Perfluorochemical Enhanced Gene Delivery to Lung”(Declined in order to Accept the National CF Foundation Award) 1998

  • Mentored Scientist Clinical Development Award (CIDA), NHLBI HL03864, $381,250 “Perfluorochemical Enhanced Gene Delivery to Lung” 1998-2003

  • National Cystic Fibrosis Foundation Research Grant) $120,000 “Perfluorocarbon-Enhanced Gene Delivery to Primate Lung” 2000-2002

  • American Lung Association (Washington State) Research Grant, $100,000 “Mechanism of PFC Liquid Enhanced Gene Delivery to Lung” 2000-2002

  • University of Washington Primate Research Center $50,000 “Effect of Aerosolized PFC on AAV-Mediated Gene Expression in Lung” 2001

  • Vermont Lung Association Proctor Award $20,000 “Mechanism of PFC Liquid Enhanced Gene Delivery to Lung” 2000-2002

  • Member, Respiratory Tract Committee, American Society of Gene Therapy 2001-2004

  • Faculty Development of Award, Univ of Vermont College of Med $70,000 Funds a Post-Doctoral Researcher for Two Years. 2002-2004

  • Fletcher Allen Trustees’ Research Development Fund Award $64,000 “Inhaled Insulin for Cystic Fibrosis-Related Diabetes” 2002-2004